Monte Rosa Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $534k | 72k | 7.41 |
| 2025-06-30 | $488k | 108k | 4.51 |
| 2025-03-31 | $425k | 92k | 4.64 |
| 2024-12-31 | $412k | 59k | 6.94 |
| 2024-09-30 | $134k | 25k | 5.30 |
| 2024-06-30 | $87k | 23k | 3.74 |
| 2024-03-31 | $290k | 41k | 7.05 |
| 2023-12-31 | $214k | 38k | 5.65 |
| 2023-09-30 | $112k | 23k | 4.79 |
| 2023-06-30 | $163k | 24k | 6.85 |
| 2023-03-31 | $81k | 10k | 7.79 |
| 2022-12-31 | $70k | 9.2k | 7.61 |
| 2022-03-31 | $412k | 29k | 14.01 |
| 2021-12-31 | $67k | 3.3k | 20.55 |